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ABSTRACT An a-bungarotoxin-binding protein was pu-
rified from chick optic lobe and brain by an improved method. 
Previous and present observations justify its designation as a 
brain nicotinic acetylcholine receptor (AcChoR). It contains 
subunits whose apparent molecular weights are somewhat 
larger than those of subunits ol peripheral AcChoRs. The size 
of the optic lobe AcChoR complex is greater than that of the 
peripheral receptor when estimated from its sedimentation 
behavior. Brain AcChoR subunits can be specifically precip-
itated by a monoclonal alitibody directed against chick muscle 
AcChoR. Amino-terminal amino acid sequence analysis was 
performed on AcChoR preparations and isolated subunits from 
the optic lobe and from the rest of the chick brain. The 
sequences obtained demonstrate that, at least for the lowest 
molecular weight component, the AcChoRs from different 
brain areas are identical and they are highly homologous to 
muscle AcChoR. It is concluded that the brain a-bungarotoxin-
biuding proteiu is iudeed a nicotinic AcChoR and is encoded by 
a set of geues that is different from, but strongly related to, that 
for the muscle AcChoR. 
The nicotinic acetylcholine receptors (AcChoRs) from ver-
tebrate skeletal muscle (1, 2) and from fish electric organ (3) 
are pseudosymmetric complex proteins, composed of four 
homologous subunits (a, {3, y, and 8) in the stoichiometry 
az.f3-y8. This homology has been fully quantitated in certain 
cases by eDNA cloning and total sequencing of subunits from 
both muscle and electric organ AcChoR (4-7). Each of the 
four subunit types is specified by a separate gene, but the 
homologies found between subunits and between species 
show that these genes belong to a single family. 
Some regions of the vertebrate brain contain a nicotinic 
AcChoR with pharmacological characteristics similar but not 
identical to those of muscle AcChoR (8, 9). In addition, some 
brain areas and peripheral ganglia contain high-affinity bind-
ing sites for a-bungarotoxin (a-BTX) and similar snake 
toxins, which are known to bind to periphera' \cChoR. 
However, the identity of the neuronal toxin-bin< : compo-
nent with a nicotinic AcChoR has been disputed ( reviews, 
see refs. 10 and 11). In avian and amphibian opt.~ .obe (10), 
human medullablastoma cells (12), and some sympathetic 
ganglionic sites (11, 13-17) there is evidence in favor of this 
identity, even though a-BTX binding does not always block 
receptor function. From avian optic lobe (10), where a-BTX 
blocks AcChoR function, the a-BTX binding protein has 
been purified (18). This protein displays the ligand-binding 
characteristics of a nicotinic receptor (2) and it can be 
covalently labeled by the affinity reagent bromoacetylcholine 
(BrAcCho) (18) in a manner similar to muscle and electric 
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organ. It also shows distinct immunological crossreactivity 
with an antiserum to mammalian muscle AcChoR (18) and 
with some monoclonal antibodies raised against chicken 
muscle AcChoR (2, 19). Identification of this brain a-BTX-
binding protein as a true AcChoR and resolution of the 
question as to whether it is encoded by genes of the family 
described above for the nonneuronal AcChoRs requires 
information on the nature and amino acid sequence of its 
subunits. We provide here evidence that the central nervous 
system (CNS) a-BTX-binding protein is a nicotinic AcChoR 
structurally homologous to peripheral AcChoR. 
METHODS AND MATERIALS 
Methods and materials not specified were as given by 
Norman et a/. (18). Optic lobes (100-200 per preparation) 
were dissected from 1-day old chicks and used either freshly 
or after freezing in liquid N2 and stored at -70"C. The 
remainder of the brains after optic lobe removal was similarly 
frozen and stored at -70°C. This part of the chick CNS will 
be referred to as "brain." Vacuum dialysis was through 
Spectrapor 25K tubing, prewashed in 2% NaHC03 for 45 min 
at 40°C, then in 1% NaDodS04 at 40°C, and extensively 
rinsed with water. All water used for samples for sequencing 
was redistilled in glass. 
Preparation of AcChoR. Chick optic lobes or brains were 
homogenized (glass/Teflon, 10 passes) in 10 vol of buffer 1 
(50 mM sodium phosphate, pH 7.0/5 mM EDTA/1 mM 
EGT A) containing also 1 mM phenylmethylsulfonyl fluoride, 
bacitracin at 100 p.g/ml, soybean trypsin inhibitor at 25 
p.g/ml, 1 mM benzamidine, and (except where noted) 0.5 mM 
N-ethylmaleimide or 2 mM iodoacetamide. The pellet col-
lected at 100,000 x g was homogenized in 4 vol of buffer 1 
containing the protease inhibitors less N-ethylmaleimide. 
Triton X -100 was added to a final concentration of 1% and the 
extract was shaken at ooc for 1 hr. The supernatant (100,000 
x g, 45 min) was filtered through glass wdol and shaken at 4°C 
for 3 hr with 2 ml of Sej>harose-a-BTX (concentration of 
coupled toxin = 0.5 mg/ml of gel) per 100 ml of supernatant. 
The beads were washed rapidly in a column, first with 30 vol 
of buffer 1 containing 0.2% Triton X-100 and protease 
inhibitors, then with 100 vol of the latter medium containing 
1 M NaCl, and finally with 60 vol of buffer 1/0.2% Triton 
X-100. The beads were extracted with 1.5 vol of 1 M 
carbachol in buffer 1/0.2% Triton X-100 with rotation for 12 
hr at 4°C, and the extract was combined with a second 2-hr 
extract (extract a) or with 1.5 vol of 62 mM Tris·HCl, pH 
6.8/3% NaDodS04/5% (vol/vol) 2-mercaptoethanol, rotat-
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ing 1 hr at room temperature (extract b). Extract a was 
dialyzed against several changes of 10 mM sodium phos-
phate/50 mM NaCl/0.1% Triton X-100, pH 7.4. NaDod-
S04 and mercaptoethanol were added to final concentrations 
of 1.5% and 2.5%, respectively, and the samples were 
dialyzed extensively against 16.7 mM Tris·HCI/0.05% 
NaDoDS04, pH 6.8. Extract b was dialyzed similarly. 
Purification of AcCbo~ Subunits. The peptides present in 
preparations of purified AcChoR (50-200 pmol of toxin-
binding sites) were isolated by NaDodS04 gel electrophore-
sis, recovered by electroelution, and electrodesalted as 
described (20). 
The purity and integrity of the isolated subunits were 
assessed by gel electrophoresis (21). The protein bands were 
visualized by silver staining (22). The purified subunits were 
lyophilized and stored frozen. 
Amino-Terminal Amino Acid Sequence Analysis. The 
lyophilized samples were dissolved in glass-distilled water 
and 30 ~I was loaded on a Polybrene-coated glass filter disk 
in a gas-phase sequencer (Applied Biosystems, Foster City, 
CA) and submitted to amino-terminal sequence analysis by 
automated Edman degradation (23). The Polybrene-coated 
disk had been precycled by 10 cycles of automated Edman 
degradation. For each analysis 5-20 pmol of protein was 
used. Phenylthiobydantoin derivatives of amino acids were 
identified by HPLC in an IBM Cyano column (24). Typical 
repetitive yields for these analyses were between 93 and 96%. 
RESULTS AND DISCUSSION 
Purified Optic Lobe and Brain AcCboR. The method used 
for chick optic lobe and brain AcChoR purification was a 
modification of a previous method (18) and was designed to 
minimize AcChoR proteolysis. These modifications were (0 
solubilization for 1 hr in 1% Triton X-100 instead of 5% 
Lubrol PX for 2 hr; (ii) increase in the phenylmethylsulfonyl 
fluoride concentration 10-fold to 1 mM and the EDT A 5-fold 
to 5 mM; (iii) reduction of the period allowed for binding of 
AcChoR to toxin-Sepharose from 18 hr to 3 hr; (iv) omission 
of the lentillectin-Sepharose treatment and of the recycling 
previously used during the elution by carbachol. The com-
bined modifications led to some differences (as detailed 
below) in the subunit pattern and sedimentation behavior 
from those previously described (18). 
The purified a-BTX-binding component from optic lobe 
showed high-affinity binding of 12sl-labeled a-BTX (12sl-a-
BTX) with specific activities of 4000-6000 nmol/ g of protein 
in different preparations. The component purified from 
"brain" (see Methods and Materials) had similar a-BTX-
binding characteristics and specific activity. In sucrose 
density gradients the optic lobe AcChoR sedimented mostly 
as a peak with a sedimentation coefficient of 10.5 S (Fig. 1). 
For the AcChoRs from chick or other muscles (2) this value 
is about 9 S, and the molecular size of the optic lobe AcChoR 
is indeed significantly larger, as was shown by hydrodynamic 
determination with 2Hi0 correction for bound detergent (to 
be reported in detail elsewhere). 
Peptide Composition of Purified CNS AcCboR. Upon 
NaDodS04 gel electrophoresis the a-BTX-binding proteins 
from either chick optic lobe or brain had very similar peptide 
compositions. Different preparations consistently contained 
four or five major components, whose molecular weights 
ranged between 4S,OOO and 72,000 (Fig. 2). The component of 
lightest molecular weight (48,000) sometimes migrated in a 
diffuse form, which was poorly stained by Coomassie blue. 
This component was also very sensitive to proteolytic deg-
radation, as demonstrated by its progressive disappearance 
with more lengthy purification procedures. Similar patterns 
were observed when the specifically bound protein was either 
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FIG. 1. Separation of the purified receptor by centrifugation in a 
5-20% sucrose gradient in 10 mM sodium phosphate, pH 7/50 mM 
NaCI/0.2% Triton X-100. Each fraction was assayed for the binding 
of 1251-a-BTX (e). Calibration standards were yeast alcohol dehy-
drogenase, bovine catalase, and Escherichia coli J3-galactosidase, 
with their s20,w values (D) in S units on the right-hand scale. In four 
such determinations on different preparations, the receptor peak was 
centered (arrow) at a mean of 10.5 Son the linear plot shown. 
stripped from the toxin-Sepharose NaDodS04 or specifically 
eluted by carbachol. 
Amino-Terminal Amino Acid Sequencing. All the peptides 
contained in purified' optic lobe AcChoR were isolated (Fig. 
3) and submitted to amino-terminal amino acid sequencing. 
The lowest molecular weight component gave a readily 
A B 
M, OL St M, 
X 10- 3 X 10- 3 
234567 
--92 
62~- -67 
56~ 
48- - -43 
- -31 
- -21 
FIG. 2. Analysis of the subunit composition of AcChoR from 
chick optic lobe by NaDodS04 gel electrophoresis. (A) AcChoR from 
optic lobe (OL) was eluted from the a-BTX-Sepharose affinity gel 
with 62 mM Tris·HCI buffer, pH 6.8, containing 3% NaDodS04 and 
5% mercaptoethanol. After electrophoresis the proteins were silver 
stained. Standard proteins (St) used were phosphorylase b, bovine 
serum albumin, glutamate dehydrogenase, ovalbumin, lactate dehy-
drogenase, and carbonic anhydrase. (B) Autoradiogram of [1251]-
iodinated AcChoR. The sample run in track 4 was radioiodinated by 
using the chloramine-T method while adsorbed to the a-BTX-
Sepharose resin; it was then washed and eluted with 62 mM Tris·HCI 
buffer, pH 6.8, containing 3% NaDodS04 and 5% mercaptoethanol. 
Aliquots of material, eluted from the a-BTX affinity gel with 
carbachol, were labeled with 1251 and gel flltered to remove free 1251. 
Samples were then incubated at 22oc for 2¥2 hr with nonimmune 
serum (tracks 3 and 5) or with monoclonal antibody 782 (19), raised 
against chick muscle AcChoR (tracks 2 and 6); after reaction (22"C 
for 2 hr) with staphylococcal protein A-Sepharose, the resultant 
precipitates were washed, dissolved in NaDodS04 buffer (see 
above), and subjected to electrophoresis. 1251-labeled standard pro-
teins Q>ovine serum albumin, catalase, ovalbumin, and lactate 
dehydrogenase) were run in tracks 1 and 7. The monoclonal antibody 
selectively precipitated polypeptides of M, 48,000, 56,000, 69,000, 
and 72,000 (tracks 2 and 6), while negligible radioactivity was 
precipitated in control samples (tracks 3 and 5). 
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FIG. 3. NaDodS04 gel electrophoresis of isolated subunits from 
chick optic lobe AcChoR visualized by silver staining. St, Bio-Rad 
low molecular weight standards; lanes 1-S, isolated subunits in order 
of increasing molecular weight. Band 1 (M., 48,000) gave the 
sequence reported in Fig. 4 and barid 2 (M., S6,000) has p~viously 
been shown to be labeled by BrAcCho (18). Bands 3 (M., 62,000) and 
4 (M., 66,000) together with 2 can be precipitated by monoclonal 
antibody 7B2. 
identifiable single sequence, reported in Fig. 4. Comparison 
of this sequence with the known amino-terminal sequences of 
Torpedo, Electrophorus, and calf peripheral AcCho~ 
subunits; the a subunit of chick and htiman muscle AcCho.R 
(1, 25-28), and the other subunits of chick muscle AcChoR 
(unpublished observations) revealed that the ·optic lobe 
sequence is, although 4ifferent, hi8hly homologous to the 
subunits of the other AcChoRs, the highest degree of homol-
ogy beihg with the a subunits, and among these with the a 
subunit of Torpedo (see Fig. 4 and Table 1). This woUld 
indicate that the divergence of peripheral and central Jtico-
tinic receptors happened very early during vertebrate evo-
lution, as indicated also by the phylogenetic tree depicted in 
Fig. 5. Amino-terminal amino acid sequence analysis of the 
other isoiated subunits from optic lobe AcChoR did not yield 
any signal above the high background consistently present, 
indicating that these subunits had blockefi amino termini. To 
determine whether this blockage was caused by the isolation 
of the subunits from NaDodS04 gels, intact optic lobe 
AcChoR preparations were submitted to simultaneous ami-
no-terminal analysis of all the sequences present in such 
preparations. Only one signal was detected, which corre-
--------------------------------BRAIN XEFETKLYKELLKNVNPLEXPUAXD 
--------------------------------
RAY SEHETRLVANLLENYNKVIRPVEHH 
EEL SEDETRLVKLNFSGYNKVVRPVNHF 
CALF SEHETRLVAKLFEDYNSVVRPVEDH 
CHICK XEHETRLVDDLFRDYSKVVRPVENH 
FIG. 4. Comparison of the amino-terminal amino acid sequence 
(standard one-letter code) obtained for the Mr 48,000 subunit of brain 
AcChoR (top) and the amino-terminal sequences of known a 
subunits of peripheral AcChoR from Torpedo electroplax (2S), 
Electrophorus electroplax and muscle (20, 26), and calf muscle (1). 
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Table L Percent identity betweeri the amino-terminal sequence 
obtained for the lightest component of chick brain AcChoR and 
the amino-terminal segment of subunits from peripheral AcChoRs 
Subunit Chick Ray Eel Calf Human 
a 3S 48 43 39 39 
~ 38 30 39 3S 
-y 26 30 
8 28 32 24 
Sequences are from the following: chick muscle a subunit, ref. 27; 
chick mtiscle fJ and 8 subunits, unpublished observations; Torpedo 
ray, ref. 2S; Elecirophorus eel, ref. 26; calf, ref. 1; and human, ref. 
28. 
spoaded to the sequence reported above for the lightest 
component of optic lobe AcChoR, and it was therefore 
concluded that animo-terminus blockage preexisted subunit 
isolation. Due to the agonizingly low amounts of AcChoR 
present in the rest of the chick brain the isolation of individual 
subunits for sequencing was not feasible. Intact brain prep-
arations were submitted to simultaneous amino-terminal 
analysis as described above. Only one signal was present 
above a high background, which indicated the presence of 
other proteins with blocked amino termini. The sequence 
obtained was identical to that of the lowest molecular weight 
component of optic lobe AcChoR. These data, together with 
a Chain Brain a Chain 
Chicken 
to a-/3/Y-8 ruplication -
/3 Choin 
Chicken 
FIG. S. A phylogenetic tree generated from the amino-terminal 
sequence data of the known a and fJ subunits of peripheral AcChoRs 
(1, 7, 20, 2S-27) and chicken brain AcChoR by tising the best-fit 
matrix method.§ Each branch point represents a nodal or ancestral 
sequence. The numbers associated with each branch length represent 
the "accepted point mutations" (P AMs) per 100 amino acid residues 
that occurted in generating ,the contemporary AcChoR subunits. The 
positioll of the a/{3 duplication is arbitrarily located along a 2S-PAM 
seament separating the ancestral sequences of modem a and f3 
subunits. The • indicates the divergence of the a subunit of the brain 
AcChoR. from the ancestor of the peripheral a subunits. 
IOrcutt, B. C. & Dayhoff, M. 0. (197S) Matrix Topology Program-
MATTOP, NBR Report No. 09810-7!11101 (Natl. Biomed. Res. 
Found., Washington, D.C.). 
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the similar gel patterns and the indistinguishable reactivities 
(18, 19) to antibodies against muscle AcChoR (both polyclo-
nal and monoclonal), suggest that the AcChoRs from the 
optic lobe and from other regions of the chick brain are 
similar if not identical complex proteins. 
In the absence of sequencing data, other methods had to be 
used to identify the other peptides as AcChoR subunits. The 
peptide of apparent Mr 56,000 has already been shown (18) to 
be the site of specific alkylation by the affinity reagent 
BrAcCho and is therefore part of the receptor, since it must 
contain at least part of one of the binding sites for cholinergic 
ligands. In the case of peripheral AcChoR and under similar 
conditions, only the a subunit is labeled by BrAcCho (3). 
However, since multiple ligand binding sites have been 
shown to exist, at least on Torpedo AcChoR (29-32), and 
since BrAcCho itself can label other Torpedo AcChoR 
subunits under different labeling conditions (unpublished 
observations), it is reasonable to conclude that in the case of 
the highly divergent CNS receptor a different subunit can be 
more easily labeled by BrAcCho. Likewise 1251-a-BTX can 
be crosslinked to the optic lobe Mr 56,000 subunit by using 
dimethyl suberimidate (ref. 18 and unpublished observa-
tions). Hence, the Mr 56,000 subunit carries a high-affinity 
site for AcCho and for a-BTX, as is known for the a subunit 
of the peripheral AcChoR (3). 
Further evidence that other polypeptides are components 
of the AcChoR was obtained by virtue of their immunoreac-
tivity. For this test, we used a monoclonal antibody, 7B2, 
raised against chick muscle AcChoR, which has been shown 
to give distinct crossreaction with the a-BTX complex of the 
AcChoR purified from chick optic lobe (19). Optic lobe 
AcChoR was labeled with 1251 and immunoprecipitated by 
antibody 7B2, and the precipitate was extracted in 
NaDodS04 solution and analyzed. Three receptor bands 
were present (Fig. 2B), which corresponded to the Mr 48,000, 
56,000, and 69,000 subunits observed upon NaDodS04 gel 
electrophoresis of noniodinated receptor. Note that this 
includes the subunit of lowest molecular weight, for which 
the sequence data of Fig. 4 reveal a correspondence with the 
a subunit of peripheral AcChoR. Iodination also caused some 
breakdown of the two higher molecular weight subunits, 
which appeared weaker upon fluorography of 1251-AcChoR 
when compared with Coomassie- or silver-stained gels of 
noniodinated AcChoR (Figs. 1 and 3). A Mr 72,000 polypep-
tide was precipitated but was faint (Fig. 2B); it therefore 
remains to be established whether this is an AcChoR subunit. 
The latter statement applies also to the Mr 62,000 polypep-
tide, which is not readily seen in iodinated or (Fig. 2A) 
silver-stained AcChoR analyses. 
The data reported here permit the identification of the Mr 
48,000, 56,000, and 69,000 polypeptides as subunits of the 
central AcChoR. In the absence of amino terminals available 
for sequencing it was not possible to determine the stoichi-
ometry of the receptor subunits, or to ascertain whether the 
other two polypeptides present in N aDodS04 gels of purified 
CNS receptors, having molecular weights of 62,000 and 
72,000, represent one or more contaminants or are AcChoR 
subunits or different proteolytic products or post-translation-
al modifications of one subunit. We can exclude the possi-
bility that the Mr 48,000 subunit is a breakdown product of 
any of the others, since the amino terminus is different from 
theirs (not blocked) and corresponds in sequence to the true 
amino terminus of the peripheral AcChoR a subunit. Actin, 
which is found complexed to the calf muscle AcChoR (1) and 
which migrates to the Mr 45,000-48,000 region and has a 
blocked amino terminus, was absent here, as shown by 
comparison with a chicken gizzard actin standard and by the 
lack of change of the pattern upon the treatment of the 
AcChoR with anti-actin antibody. 
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These results establish that the CNS a-BTX-binding pro-
tein is indeed a nicotinic receptor similar to the receptors 
found in muscle and electric organ. Brain and muscle Ac-
ChoR from the same species, although homologous, must be 
encoded by different genes and must have originated from the 
same ancestral gene. Since the similarity between a subunits 
of central and peripheral receptors from the same animal is 
much less than between a subunits of peripheral AcChoRs 
from different animals (Table 1), it may be concluded that the 
central and peripheral nicotinic receptors diverged very early 
during vertebrate evolution (see Fig. 5). These divergences 
from an ancestral common structure explain well the phar-
macological characteristics of these receptors, which only 
partially overlap. Similarly, the partial structural identity 
explains why in certain cases polyclonal and monoclonal 
antibodies raised against peripheral AcChoRs failed to rec-
ognize central receptors (9, 33) and antibodies against chick 
optic lobe receptor did not bind to peripheral AcChoR from 
chick or from Torpedo californica (34). Our data do not 
exclude the possibility that within the nervous system dif-
ferent nicotinic receptors may exist. This possibility is 
supported by the following findings: (i) neuronal proteins 
exist that do not bind a-BTX but bind anti-muscle AcChoR 
antibodies as well as other a-BTX-like snake venom toxins 
(15, 35, 36) and (ii) in chick sympathetic ganglia two nicotinic 
receptors with slightly different pharmacological specificities 
exist, both of which bind a-BTX-like toxins, but only one of 
them is functionally blocked as a consequence of a-BTX 
binding (13, 16). 
It has been reported that antibodies raised against chick 
optic lobe receptor crossreact not with chick muscle AcChoR 
but with the receptor from the PC12 neuronal cell line (34). 
This raises the possibility that neuronal nicotinic receptors 
are highly conserved proteins and that the genes encoding 
chick brain AcChoR, whose isolation will be greatly facili-
tated by the reported sequence data, will permit the isolation 
of mammalian brain AcChoR genes. 
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